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Congenital insensitivity to pain with anhidrosis is an autosomal recessive hereditary disorder char-
acterized by recurrent episodic fever, anhidrosis (inability to sweat), absence of reaction to nox-
ious stimuli, self-mutilating behavior, and mental retardation. The human TRKA gene (NTRK1),
located on chromosome 1q21-q22 encodes the receptor tyrosine kinase for nerve growth factor.
We reported that TRKA is the gene responsible for CIPA and we developed a comprehensive
strategy to screen for TRKA mutations and polymorphisms, as based on the genes structure and
organization. Here we report eight novel mutations detected as either a homozygous or heterozy-
gous state in nine CIPA families from five countries. Mendelian inheritance of the mutations was
confirmed in seven families for which samples from either parent were available. However, non-
mendelian inheritance seems likely for the family when only samples from the mother and sib-
lings, (but not from the father) were available. A paternal uniparental disomy for chromosome 1 is
likely to be the cause of reduction to homozygosity of the TRKA gene mutation in this family.
Interestingly, a Hispanic patient from the USA has two autosomal genetic disorders, CIPA and
pyruvate kinase deficiency, whose genetic loci are both mapped to a closely linked chromosomal
region. A splice mutation and a missense mutation were detected in the TRKA and PKLR genes
from the homozygous proband, respectively. Thus, concomitant occurrence of two disorders is
ascribed to a combination of two separate mutant genes, not a contiguous gene syndrome. This
finding suggests a mechanism responsible for two autosomal genetic disorders in one patient. All
these data further support findings that TRKA defects can cause CIPA in various ethnic groups.
This will aid in diagnosis and genetic counseling of this painless but severe genetic disorder. Hum
Mutat 18:308318, 2001. ' 2001 Wiley-Liss, Inc.
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We have also identified a complete paternal
isodisomy for chromosome 1 as the cause of re-
duction to homozygosity of the TRKA gene muta-
tion, leading to CIPA [Miura et al., 2000a].
Recently, we examined effects of TRKA missense
mutations on autophosphorylation of the receptor
tyrosine kinase for NGF [Mardy et al., 2001]. These
studies led to the genetic diagnosis of CIPA, which
was previously established on the basis of clinical
findings, pharmacological tests, and peripheral
nerve biopsy.
We report here clinical profiles and eight novel
TRKA mutations as homozygous or compound
heterozygous in nine families with CIPA from
Kuwait, Italy, the United States, The Nether-
lands, and Japan. We also describe a putative
uniparental disomy as the cause of reduction to
homozygosity of the TRKA gene mutation in a
family and a linkage of two autosomal recessive
genetic disorders, CIPA and pyruvate kinase
deficiency, in another family.
MATERIALS AND METHODS
Patients
The nine affected families with CIPA were
three each from Kuwait (KI-109, KI-110, and
KI-111) and Italy (KI-112, KI-113, and KI-114);
and one each from the United States (KI-115),
The Netherlands (KI-116), and Japan (KI-25).
Blood was collected from patients with CIPA and
from family members referred to the investiga-
tors. Informed consent was obtained from all
these tested subjects.
Family KI-109. The proband is a 3-month-old
boy born to consanguineous parents. He has three
siblings who are unaffected. He first presented at
the age of 24 hr with fever that persisted. He did
not respond to painful stimuli such as blood sam-
pling. Extensive investigations revealed no infec-
tious cause for the fever. The parents reported that
he was never seen sweating. This family was re-
ferred for the genetic diagnosis of CIPA.
Family KI-110. The proband is a 2-year-old
boy with unexplained fevers, febrile convulsions,
INTRODUCTION
Congenital insensitivity to pain with anhidro-
sis (CIPA; MIM# 256800) is an autosomal re-
cessive disorder characterized by recurrent
episodic fever depending on high environmen-
tal temperature, anhidrosis (inability to sweat),
absence of reaction to noxious stimuli, self-mu-
tilating behavior, and mental retardation [Dyck,
1984; McKusick, 1994; Swanson, 1963]. CIPA
is also classified as hereditary sensory and auto-
nomic neuropathy type IV [Dyck, 1984]. Vari-
ous neurotrophic factors (neurotrophin) support
cell survival, growth, and differentiation in ner-
vous systems. Nerve growth factor (NGF), the
first neurotrophic factor to be identified, sup-
ports the survival of sympathetic ganglion neu-
rons and nociceptive sensory neurons in dorsal
root ganglia, derived from the neural crest, and
ascending cholinergic neurons of the basal fore-
brain [Levi-Montalcini, 1987; Thoenen and
Barde, 1980]. TRKA is a receptor tyrosine ki-
nase that is phosphorylated in response to NGF
[Kaplan et al., 1991; Klein et al., 1991].
We identified the genetic basis for CIPA when
we detected loss-of-function mutations in the
TRKA (also NTRK1; MIM# 191315) gene de-
rived from affected patients [Indo et al., 1996].
CIPA is the first human genetic disorder implicated
in the neurotrophin signal transduction system.
The anomalous pain and temperature sensation
and anhidrosis in CIPA are probably because of
the absence of afferent neurons activated by tis-
sue-damaging stimuli and a loss of sympathetic
innervation of eccrine sweat glands, respectively.
Human TRKA (NTRK1) gene maps to chromo-
some 1q21-q22 [Weier et al., 1995]. Recently, we
developed a strategy to screen for TRKA muta-
tions, on the basis of the structure and organiza-
tion of the gene [Indo et al., 1997; Mardy et al.,
1999] and we characterized eight intragenic poly-
morphic sites [Miura et al., 2000b]. Other investi-
gators have also detected and reported mutations
in the TRKA from CIPA patients [Greco et al.,
1999; Shatzky et al., 2000; Yotsumoto et al., 1999].
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and mutilation of his tongue for which he had
all teeth extracted. He did not respond to pain-
ful stimuli such as blood sampling. Extensive
investigations revealed no infectious cause for
the fever. He is hypotonic, anhidrotic, and de-
layed in development. This family was also re-
ferred for the genetic diagnosis of CIPA.
Family KI-111. The patient is a 9-year-old
girl born to consanguineous parents. She has two
unaffected younger siblings (a brother and a sis-
ter). During infancy, she often had unexplained
fever especially in the hot weather. She shows
no response to noxious stimuli and no sweating
under hot environmental conditions. She has
demonstrated self-mutilating behavior such as
avulsion of teeth and biting of fingertips. Her
right leg is amputated below the knee and sev-
eral toes on her left foot are missing.
Family KI-112. The patient, a 13-year-old
boy, presents a complete phenotype of CIPA, in-
cluding recurrent episodes of unexplained fever,
anhidrosis, absence of reaction to noxious
stimuli, self-mutilating behavior, and mental re-
tardation. Parents denied consanguinity.
Family KI-113. The patient was a 22-year-old
man, the first child of healthy consanguineous
parents (first cousins), who was previously re-
ported as two brothers with a variant of heredi-
tary sensory neuropathy [Pavone et al., 1992].
His clinical phenotype was described as a variant
form of CIPA because a sural nerve biopsy showed
neuropathological findings consistent with this
disorder but with normal sweating function and
absence of recurrent fever. However, re-exami-
nation with pilocarpine iontophoresis showed that
this patent was indeed anhidrotic. He died at
age 25 years due to renal dysfunction and spine
fractures. His younger brother with the same
phenotype died at age 15 years due to an infec-
tion-related disorder. Data on their six-year-old
younger sister were not previously reported but
she presents a CIPA phenotype.
Family KI-114. The patient, an 18-year-old
girl, presents a mild phenotype with insensitiv-
ity to pain, hypohidrosis, severe bone involve-
ment, and no apparent mental retardation.
Parents are not consanguineous.
Family KI-115. The patient is a five-year-old
Hispanic boy whose parents were born in a small
town in Mexico, but are not known to be re-
lated. He began to exhibit self-mutilating behav-
ior in infancy after his teeth erupted. He required
three surgeries for tongue reconstruction and
eventually had all of his primary teeth extracted.
He has also been biting and pulling out his fin-
gernails. By age four, he had fractures in meta-
tarsals of both feet, without any known trauma
and no signs of pain. He developed deep ulcer-
ations after casts were put on but appeared to
have no pain. He has had recurrent hyperpyr-
exia with fevers as high as 41° C and experienced
two episodes of febrile seizures. He frequently
has a fever in warm weather or when he is over-
dressed but no observed diaphoresis. His growth
is poor, with height and weight consistently be-
low the 5th percentile, and he has developmen-
tal delay as well as hyperkinetic behavior.
Examination of nerve conduction velocities and
a sural nerve biopsy confirmed the diagnosis of
CIPA. In addition to neurological findings, he
has had since birth a moderately severe hemo-
lytic anemia. Initially, he received sporadic trans-
fusions when his hemoglobin dropped as low as
5 g/dl, usually associated with an intercurrent
illness. At age three years, pyruvate kinase defi-
ciency was diagnosed based on an enzyme assay
by Dr. E. Beutlers laboratory at Scripps Research
Institute. Both his parents had enzyme levels
consistent with heterozygosity. The father has a
mild hemolytic anemia and the mother is clini-
cally asymptomatic. At age 5 1/2 years a sple-
nectomy was done, with minimal benefits, and
repetitive transfusions with iron-chelation
therapy were given to the boy.
Family KI-116. The patient is a 7-year-old
boy. His parents are of Dutch ancestry and con-
sanguinity is denied. Postnatally hypothermia
was present, probably due to anomalous regu-
lation of his body temperature. At age six
months he developed unexplained febrile epi-
sodes in the summer months. He did not want
to walk even at the age of five years. His ankles
were swollen but seemed to be painless. Ra-
diological studies were suggestive of arthritis.
He presents anhidrosis and has hyperkeratosis
of the palms and soles. His response to painful
stimuli is nil. Intradermal injection of histamine
provoked no axonal reflex. He was develop-
mentally retarded and a formal assessment re-
vealed that his IQ was 70.
Family KI-25. The patient is a 2-year-old girl
born normally at term after an uneventful preg-
nancy to non-consanguineous healthy Japanese
parents. At age four months she presented with
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an oral ulcer that seemed to be painless. She also
had febrile episodes but extensive investigations
revealed no cause. She did not cry during blood
sampling. She did not sweat and her skin was
dry. Skin biopsy indicated the presence of ec-
crine sweat glands but their innervation was
absent. Conduction velocity of peripheral nerves
was within a normal range. Sural nerve biopsy
revealed a decrease of unmyelinated and small
myelinated nerves. She was hypotonic and de-
velopmentally retarded. She repeated self-muti-
lating behaviors such as biting her tongue.
Genetic Analysis
Numbering system for amino acids and nucle-
otides. Mutations are designated according con-
ventional nomenclature [Antonarakis, 1998],
using the TRKA cDNA sequence and amino
acid numbering [Martin-Zanca et al., 1989], and
the structure and organization of the human
TRKA gene [Indo et al., 1997].
TRKA amplifications and DNA sequencing.
TRKA exons were amplified from genomic DNA
using specific primers derived from the 5¢  and 3¢
intronic or exonic sequences, and AmpliTaq
Gold (Applied Biosystems, Tokyo, Japan) or the
Expand Long PCR system enzyme (Roche Mo-
lecular Biochemicals, Mannheim, Germany).
The corresponding polymerase chain reaction
(PCR) products were sequenced directly. The
primers and sequencing of PCR products have
been described elsewhere [Mardy et al., 1999].
Sequencing of the PCR products was done us-
ing dRhodamine Terminator Cycle Sequencing
Kits (Applied Biosystems, Tokyo, Japan). Se-
quences were resolved and analyzed on an ABI
PRISM 310 Genetic Analyzer (Applied Bio-
systems, Tokyo, Japan).
Restriction digestion analysis. For analysis of
Gln176Ter mutation from KI-109 and KI-110
families, genomic DNA was amplified and the
following set of primers was used. Forward
primer: 5¢ -CTCCCTCTTATCCCCTGTGA-3¢ ;
reverse primer: 5 ¢ -TTTCAGTGCTTGCTC-
AGTGCC-3¢ ). PCR products were digested with
a restriction enzyme PstI and electrophoresed
onto an agarose gel.
Haplotype and Allelotype Analyses
In family KI-111, haplotypes of the proband
and her mother were characterized using eight
single nucleotide polymorphic markers and one
microsatellite marker (D1S506) within the
TRKA locus, as described elsewhere [Cargill et
al., 1999; Miura et al., 2000b]. Microsatellite
markers outside the TRKA locus spanning the
entire chromosome 1 were characterized. Each
marker was amplified from genomic DNA by
AmpliTaq Gold and primer pairs of the Linkage
Mapping Set Version 2 (Applied Biosystems),
according to the manufacturers protocol. PCR
products were resolved on an ABI PRISM 310
Genetic Analyzer, and the results were analyzed
using ABI PRISM GeneScan and Genotyper
software (Applied Biosystems).
RESULTS
Mutation Analysis of TRKA Gene in CIPA
Families
Nine unrelated CIPA families were screened
for mutations in the TRKA gene. All 17 exons
of the TRKA gene, including their flanking
intronic sequences, were amplified from the ge-
nomic DNA of each patient with CIPA. All ex-
ons and intron-exon boundaries were sequenced.
Mutations detected by PCR methods were con-
firmed on a second PCR product and were not
detected in 100 normal chromosomes [Mardy
et al., 1999; Miura et al., 2000b].
In family KI-109, we found a C to T transi-
tion at nucleotide 610 in exon 5, which changes
a Gln to a termination codon at amino acid 176
(Gln176Ter) in the proband (Table 1 and Fig.
1). Parents and three siblings were also se-
quenced. The substitution destroys a restriction
site for PstI. Digestion analysis with this enzyme
also demonstrated that the proband and parents
are homozygous and heterozygous, respectively.
Three unaffected siblings were heterozygous for
the substitution.
In family KI-110, we also detected the same
substitution as described for KI-109 (Table 1 and
Fig. 1). Parents were also sequenced. The
proband and parents were homozygous and
heterozygous for this substitution, respectively.
These two families, KI-109 and KI-110, are not
apparently related although they are from the
same countries.
In family KI-111, direct sequencing of samples
from the patient revealed a homozygous eight
base pair insertion (GGGACATC) between
nucleotides 1596 and 1597 in exon 13, which
causes a frameshift and a truncation after amino
acid Val 505 (Table 1 and Fig. 1). Mother and
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two siblings were also sequenced. However, we
did not detect mutation in the DNA samples
from the mother and two siblings. DNA from
the father was not available. We confirmed this
sequence analysis when we used DNA from fresh
blood samples. To define the mode of inherit-
ance in this family, we characterized haplotypes
of the proband and her mother, using eight single
nucleotide polymorphic markers and one
microsatellite marker (D1S506) within the
TRKA locus, as described elsewhere [Cargill et
al., 1999; Miura et al., 2000a; Miura et al.,
2000b]. Polymorphism analysis of the TRKA lo-
cus revealed that the patient was homozygous
(Fig. 1: lower part). Analyses of the single nucle-
otide polymorphism (SNP) site in intron 5 and
the D1S506 in intron 12 revealed that the pa-
tient and her mother were homozygous and het-
erozygous, respectively. Her two siblings were
also heterozygous for the D1S506. Thus, we ex-
cluded the possibility that the mother had a large
deletion in the TRKA gene. Further analysis of
the SNP site in exon 14 (c.1794 C/T) revealed
that the patient and her mother were homozy-
gous C and T, respectively (Fig. 1: lower part).
These analyses strongly indicate the non-Men-
delian inheritance of the TRKA locus haplotype
in this family.
Two bases TC at nucleotides 475-476 were
deleted in exon 4 in a male patient with CIPA
of family KI-112 (Table 1 and Fig. 1). The dele-
tion causes a frameshift and premature termi-
nation codon after amino acid Ser 131. Parents
were also sequenced. The patient and parents
were homozygous and heterozygous, respectively.
Thus, the deletion is apparently the cause of
CIPA in this family. The same mutation was pre-
viously reported in a Japanese family [Miura et
al., 2000b]. We determined a haplotype of the
proband in Italian family KI-112. The proband
was homozygous for nine polymorphic sites of
the TRKA locus that we examined. This strongly
suggests that parents share the same TRKA
mutant allele linked to the same haplotype, al-
though they denied consanguinity.
In family KI-113, two bases CG at nucleotides
1588-1589 were deleted in exon 13 of the two
siblings, a male and a female (Table 1 and Fig. 1).
Parents were also sequenced. DNA sample from
the younger boy was not available for analysis.
The deletion causes a frameshift and premature
termination codon after amino acid Arg 502. The
patients and parents were homozygous and het-
erozygous, respectively. Thus, this deletion is ap-
parently the cause of CIPA in this family.
In family KI-114, the proband was a com-
TABLE 1. Mutation Analysis of CIPA Families
Nucleotide change Mutation type & Country
Family Status (location) (predicted consequence) of origin
KI-109 Homozygote c.610C>T Nonsense Kuwait
(exon 5) (Gln176Ter)
KI-110 Homozygote c.610C>T Nonsense Kuwait
(exon 5) (Gln176Ter)
KI-111a Homozygote c.1596^1597insGGGA Frameshift Kuwait
CATC (truncation after Val505)
(exon 13)
KI-112b Homozygote c.475-476delTC Frameshift Italy
(exon 4) (truncation after Ser131)
KI113 Homozygote c.1588-1589delCG Frameshift Italy
(exon 13) (truncation after Arg502)
KI-114 Compound c.2337C>G (exon 17) Nonsense (Tyr751Ter) Italy
heterozygote c.2347C>T (exon 17) Missense (Arg 755Trp)
KI-115c Homozygote IVS9-1G>A (intron 9) Splice site USA
(aberrant splicing of exon 10) (Mexican)
KI-116 Homozygote c.2347C>T Missense Netherlands
(exon 17) (Arg 755Trp)
KI-25 Compound IVS6+1G>C (intron 6) Splicing (aberrant splicing of exon 6) Japan
heterozygote c.2210T>C (exon 16) Missense (Val709Ala)
Positions of nucleotide change are from the transcription start site, as described [Martin-Zanca et al., 1989]. The ATG initiation
codon is located at nucleotide position c.85. Structure and organization of human TRKA have been documented [Indo et al.,
1997].
aNon-Mendelian inheritance of the mutant TRKA gene was observed in this family.
bThis mutation was previously reported as one allele of a Japanese patient [Miura et al., 2000b].
cThe linkage of the mutant TRKA and PKLR genes observed in this family is responsible for CIPA and pyruvate kinase deficiency,
respectively.
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pound heterozygote, with two different muta-
tions at the TRKA locus on separate chromo-
somes (Table 1 and Fig. 1). One contained a C to
G transversion at nucleotide 2337 (c.2337C>G)
in exon 17, which changes Tyr to a termination
codon at amino acid 751 (Tyr751Ter). The
other was a C to T transition at nucleotide
2347 (c.2347C>T) in exon 17, which causes
an Arg to Trp substitution at amino acid 755
(Arg755Trp). DNA samples from both parents
were not available for sequence analysis. We
examined nine polymorphic sites in the TRKA
locus and determined haplotypes based on com-
bination of polymorphism on these sites. We
have found that the patient is heterozygous for
two sites (D1S506 and c.1740G/A), indicating
that she has two alleles (data not shown). One
mutant allele (Arg755Trp) in this patient is
probably linked to the same haplotype as that
detected in the patient KI-116 who has ho-
mozygous for Arg755Trp mutation, as described
below. Thus, analysis of polymorphic sites in
the TRKA locus showed that the patient has
two haplotypes, suggesting that two TRKA mu-
tations in exon 17 are located on two separate
chromosomes.
In a male CIPA patient of family KI-115, se-
quencing of genomic DNA revealed that a 3¢
splice site of intron 9 contained a G to A transi-
tion at the first position (IVS9-1G>A) (Table 1
and Fig. 1). Mother was also sequenced. The
proband and his mother were homozygous and
heterozygous for IVS9-1G>A, respectively.
DNA sample from his father was not available
for testing. We determined the haplotypes of the
proband in family KI-115. The proband was ho-
mozygous for nine polymorphic sites of the
TRKA locus. This strongly suggests that parents
share the same TRKA mutant allele linked to
the same haplotype, although they denied con-
FIGURE 1. Disease-associated mutations in the TRKA and polymorphism analysis in family KI-111. Mutations reported in
this study are listed above the TRKA gene diagram. Asterisk indicates mutation previously reported [Miura et al., 2000b].
Abbreviations listed below show the domain structures encoded by the corresponding exon(s) [Indo et al., 1997; Schneider
and Schweiger, 1991]. SP = signal peptide; CC-1 and CC-2 = the first and second cysteine clusters, respectively; LRMs
= leucine-rich motifs; Ig-1 and Ig-2 = the first and second immunoglobulin-like motifs, respectively; TM = transmem-
brane; JX = juxtamembrane; TK = tyrosine kinase. Amino acid numbering of the TRKA protein and structure of the
TRKA gene are described, according to Martin-Zanca et al. [1989] and Indo et al. [1997], respectively. A nomenclature
system for human gene mutations is used, according to the recommendations [Antonarakis, 1998]. Polymorphism analy-
sis of the TRKA locus, including eight single nucleotide polymorphisms (SNPs) and a microsatellite (D1S506), is shown
for Family KI-111 in lower part. A shaded box indicates the SNP locus that shows the non-Mendelian inheritance of the
TRKA in this family.
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sanguinity. Dr. E. Beutlers laboratory did an
analysis of the pyruvate kinase gene (PKLR) and
detected a G to A transition at nucleotide 1378
that causes a Val to Met substitution at amino
acid 460 (Val460Met) (data not shown). The
proband and both parents were homozygous and
heterozygous for the mutation, respectively. This
mutation has been previously found in PK defi-
cient patients [Baronciani and Beutler, 1995].
Thus, this Hispanic patient has two autosomal
genetic disorders, CIPA and pyruvate kinase
deficiency, whose genetic loci are both mapped
to 1q21-22.
In family KI-116, a homozygous C to T tran-
sition at nucleotide 2347 (c.2347C>T) in exon
17 was predicted to cause an Arg to Trp substi-
tution at amino acid 755 (Arg755Trp) (Table 1
and Fig. 1). This substitution was the same as
one allele detected in family KI-114. Parents
were also sequenced. The proband and both
parents were homozygous and heterozygous for
the substitution, respectively. We determined the
haplotypes of the proband in family KI-116. The
proband was homozygous for nine polymorphic
sites of the TRKA locus. This strongly suggests
that parents share the same TRKA mutant al-
lele linked to the same haplotype, although they
denied consanguinity. Interestingly, Arg755Trp
mutation was linked to one of two haplotypes
observed in the proband of family KI-114.
In family KI-25, the female patient was a com-
pound heterozygote, with two different mutations
at the TRKA locus, on separate chromosomes
(Table 1 and Fig. 1). In one allele, a 5¢  splice site
of intron 6 contained a G to C transversion in
the first position (IVS6+1G>C) (Table 1 and Fig.
1). The other was a T to C transition at nucle-
otide 2210 (c.2210T>C) in exon 16, which
causes a Val to Ala substitution at amino acid
709 (Val709Ala). Mother was also sequenced.
The latter mutation was derived from her mother.
DNA sample from the father was not available
for testing.
Allelotype Analysis of the Proband and Mother
in Family KI-111
To determine whether this non-Mendelian
inheritance in family KI-111 involved all or part
of chromosome 1, we did an allelotype analysis
for the patient and her mother. The patient was
homozygous at the D1S506 and its three neigh-
boring microsatellites (D1S498, D1S484, and
D1S2878). There was heterozygosity in other
microsatellite loci on chromosome 1 and she
shared at least one allele with her mother in each
locus (Fig. 2).
FIGURE 2. Allelotype analysis of the proband and her
mother with chromosome 1 markers in family KI-111. The
polymorphic markers used for this analysis are shown on
the left. Twenty-nine polymorphic markers were located
on chromosome 1 from the 1p to 1q terminal regions.
Alleles are labeled arbitrarily, according to size. The
allelotypes of the proband and her mother are shown with
one possible phasing. The father’s DNA was not available
for analysis. An arrow indicates the locus of the TRKA.
The PKLR gene is located between microsatellites D1S498
and D1S484. Shaded numbers (proband) show alleles not
detected in the mother and are probably derived from the
father. A shaded box indicates the genomic region where
a putative recombination event occurred during paternal
gametogenesis. We assume that father and mother share
one chromosome 1 not carrying the TRKA mutation, prob-
ably due to consanguinity.
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DISCUSSION
The human TRKA gene on chromosome
1q21-q22, estimated to span > 23 kb is divided
into 17 exons and 16 introns [Indo et al., 1997;
Weier et al., 1995], coding the receptor tyrosine
kinase of 790 or 796 amino acid residues (Fig.
1). A single transmembrane domain divides the
TRKA protein into an extracellular and an in-
tracellular domain [Barbacid, 1995; Bothwell,
1995; Schneider and Schweiger, 1991]. The ex-
tracellular domain, important for specific NGF
binding, includes a signal peptide, three tandem
leucine-rich motifs flanked by two cysteine clus-
ters, and two immunoglobulin-like domains (or
motifs). The intracellular domain includes a
juxtamembrane region, a tyrosine kinase do-
main, and a very short carboxyl-terminal tail.
There is a general correlation between the ge-
nomic organization of TRKA and the functional
organization of the TRKA protein product [Indo
et al., 1997].
In this report, we analyzed all coding exons from
genomic DNA by PCR direct sequencing. A total
of eight novel mutations were detected in nine
families from five countries. CIPA mutations are
spread throughout extracellular and intracellular
domains. These are two missense mutations
(Val709Ala and Arg755Trp), two frameshift mu-
tations (Arg502fs and Val505fs), two nonsense mu-
tations (Gln176Ter and Tyr751Ter), and two splice
mutations (IVS6+1G>C and IVS9-1G>A).
Two missense mutations, Val709Ala and
Arg755Trp, are probably responsible for CIPA.
They have not been observed in 100 normal
chromosomes. The Val709Ala mutation is lo-
cated in the intracellular tyrosine kinase domain
and conserved among receptor tyrosine kinases,
including human TRKB and TRKC [Martin-
Zanca et al., 1989; Nakagawara et al., 1995],
which suggests that it is important for enzyme
activity. We previously reported that the pre-
ceding residue (Gly708Ser) is also is mutated in
CIPA [Mardy et al., 1999]. The latter mutant
was expressed and its product was processed as
the wild type TRKA, but it showed a significantly
diminished NGF-stimulated autophosphoryl-
ation of the TRKA protein [Mardy et al., 2001].
It is likely that Val709Ala mutation also affects
autophosphorylation of the TRKA protein.
Arg755Trp mutation, located in the intracellu-
lar tyrosine kinase domain, was detected in a
state of either compound heterozygosity or ho-
mozygosity, in two patients. The compound het-
erozygous patient from family KI-114 has a non-
sense mutation (Tyr751Ter) on a separate
chromosome. Parents of the homozygous patient
from family KI-116 are heterozygous for the
Arg755Trp mutation. A consensus sequence
motif YXXM, which interacts phosphatidy-
linositol 3-kinase, is located at the end of tyrosine
kinase catalytic domain of the TRKA protein
(Tyr-751 in TRKA protein) [Barbacid, 1995]. A
bulky Trp substitution at the succeeding residue
(-755) of the motif may affect the function of
kinase catalytic domain. These data strongly
suggest that Arg755Trp mutation is responsible
for CIPA in the two families. Two European fami-
lies KI-114 and KI116 probably share Arg755Trp
mutation linked to the same haplotype in the
TRKA locus. It is likely that Arg755Trp muta-
tion is derived from the same ancestry. Effects
of these two missense mutations on the func-
tion of the TRKA protein are currently un-
known, and experiments are in progress to
address this question.
In the present study, the frameshift mutation,
Ser131fs, was detected as a homozygous state in
an Italian patient. Ser131fs is located in the third
leucine-rich motif of the extracellular domain
[Indo et al., 1997; Mardy et al., 1999]. This
should result in truncation of the TRKA
polypeptide in the extracellular domain. Thus,
the mutation almost certainly causes defect in
NGF signal transduction. Interestingly, the same
mutation was previously reported as one allele
of a Japanese patient who was a compound het-
erozygote for the TRKA locus [Miura et al.,
2000b]. Haplotype analysis of the TRKA locus
in these two patients suggested that the frame-
shift mutation occurred independently (data not
shown). The mutation involves a deletion of two
bases TC in repeat sequence (TC)4 encompass-
ing nucleotides 469-476. We speculate the
slipped strand mispairing as a common mecha-
nism for the mutation detected in two separate
countries [Levinson and Gutman, 1987].
Both Arg502fs andVal505fs are located in the
junction between juxtamembrane and tyrosine
kinase domains. These should result in trunca-
tion of the TRKA polypeptide. Thus, these mu-
tations almost certainly cause defects in NGF
signal transduction.
The two nonsense mutations, Gln176Ter and
Tyr751Ter, are located on the second cysteine
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cluster of the extracellular domain and the in-
tracellular tyrosine kinase domain, respectively.
Gln176Ter should result in truncation of the
TRKA polypeptide in the extracellular domain,
causing defect in the function of this receptor
tyrosine kinase for NGF. Tyr751Ter mutation is
interesting since it substitutes the Tyr-751 resi-
due in the consensus sequences motif YXXM,
which interacts phosphatidylinositol 3 ¢ -kinase
and is located at the end of the kinase catalytic
domain [Barbacid, 1995]. This should result in
truncation of the TRKA protein at the end of
the kinase catalytic domain. The truncated
TRKA protein also lacks the Tyr-785 residue
which is located in the short carboxy terminal
tail and is important for binding of phospholi-
pase Cg  [Barbacid, 1995]. Thus, Tyr751Ter prob-
ably causes defect in NGF signal transduction.
Effects of splice mutations are difficult to dem-
onstrate in vivo because CIPA patients lack neu-
rons that express the TRKA gene. Two splice site
mutations (IVS6+1G>C and IVS9-1G>A) are
predicted to cause skipping of exons 6 and 10,
respectively. These changes would result in de-
letions of a part of the first immunoglobulin-like
domain and a part of the transmembrane do-
main, respectively. The first immunoglobulin-
like domain of the TRKA protein contains two
conserved cysteines presumably involved in gen-
erating the canonical disulfide bond [Barbacid,
1995]. The domain is encoded by two exons, 6
and 7, each containing one cysteine codon [Indo
et al., 1997]. This splicing mutation is predicted
to cause deletion of a part of the first immuno-
globulin-like domain as well as disruption of the
canonical disulfide bond. Thus, IVS6+1G>C
is likely to affect the binding of NGF to the ex-
tracellular domain. Exon 10 of the TRKA en-
codes a part of transmembrane domain that
probably participates in joining the extracellu-
lar domain and intracellular domain [Indo et al.,
1997]. TRKA receptor becomes activated by
NGF-mediated dimerization of receptor mol-
ecules at the cell surface followed by auto-
phosphorylation of their intracellular tyrosine
residues [Barbacid, 1995]. Thus, the splice mu-
tation IVS9-1G>A is also likely to cause a de-
fect in NGF signal transduction.
Non-Mendelian inheritance of the TRKA
mutation in family KI-111 might be due to pa-
ternal uniparental disomy. Uniparental disomy
is defined as the presence of a chromosome pair
that derives from only one parent in a diploid
individual [Engel, 1980]. Heterodisomy is the
inheritance of a pair of chromosome homologs
from a parent, whereas isodisomy implies the
inheritance of two copies of a single parental
homolog. We reported complete paternal uni-
parental isodisomy for chromosome 1, as re-
vealed by mutation analyses of the TRKA gene
in a patient with CIPA [Miura et al., 2000a].
But a different mechanism must be considered
here since allelotype analysis revealed the pres-
ence of two chromosomes in the patient in fam-
ily KI-111. We speculate a similar mechanism to
that described for a patient with Herlitz junc-
tional epidermolysis bullosa in whom maternal
uniparental disomy of chromosome 1 with re-
duction to homozygosity of the LAMB3 locus
was revealed [Pulkkinen et al., 1997]. The CIPA
phenotype in family KI-111 might be due to pa-
ternal uniparental primary heterodisomy and
meroisodisomy of a region encompassing the
TRKA locus on chromosome 1q, resulting in
reduction to homozygosity of the paternally de-
rived insertion mutation within the TRKA gene.
Recombination event(s) probably happened
during paternal gametogenesis in a region en-
compassing the TRKA gene. A putative mecha-
nism for this chromosomal aberration could be
nondisjunction at the first meiotic division, pre-
ceded by recombination events and followed by
either gamete complementation at fertilization
or trisomy rescue at postzygotic mitosis. The
patient shares at least one allele with her mother
in all microsatellite loci studied on chromosome
1. This could be attributed to consanguinity of
her parents. We could not ascertain this hypoth-
esis because the DNA sample from her father
was not available for testing. Of course one can-
not completely exclude another mechanism(s)
for CIPA in this family.
In this report, we have described a patient
with two autosomal recessive disorders, CIPA
and pyruvate kinase deficiency, whose genetic
loci are both mapped to a closely linked region
on 1q21-q22 [Satoh et al., 1988]. Both are lo-
cated between D1S498 and D1S484 (Fig. 2: left).
Dr. E. Beutlers laboratory and our study each
detected a homozygous missense mutation in the
PKLR gene and a homozygous splice mutation
in the TRKA gene, respectively. Thus, concomi-
tant occurrence of two disorders in this family is
ascribed to a combination of two separate mu-
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tant genes, but not to a contiguous gene syn-
drome. In addition, there were no unusual clini-
cal findings in a Hispanic patient with the same
homozygous PKLR mutation previously reported
[Baronciani and Beutler, 1995], suggesting that
the linkage of these two disorders seems to be
limited to the present family. Generally, con-
comitant occurrence of two or more genetic dis-
orders mapped to the same chromosome region
suggests the possibility of a contiguous gene syn-
drome. But the present case indicates that one
cannot rule out a combination of two separate
mutant genes. This might be a rare but novel
mechanism that is responsible for two autoso-
mal genetic disorders in a patient.
Mutations responsible for CIPA are located
in the extracellular domain as well as in the in-
tracellular domain of TRKA [Mardy et al., 1999;
Miura et al., 2000b]. Mutations in the TRKA
gene are heterogeneous, although relatively com-
mon founder mutations occurred in some eth-
nic groups [Miura et al., 2000b; Shatzky et al.,
2000]. These data further confirm findings that
TRKA defects cause CIPA in various ethnic
groups. CIPA is a painless but severe genetic dis-
order associated with devastating complications,
often leading to crippling or fatal consequences.
This study will facilitate analyses of CIPA muta-
tions in TRKA and aid in diagnosing this disor-
der and for genetic counseling.
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